CoverageForm 410-K10-Q8-K13D13G13F

Agex Therapeutics, Inc.

AGECIK 0001708599 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Mar 27, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback
Full filing:tone -0.0097

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Agex Therapeutics, Inc.

NameRolesFilings
Moreadith Randall
Officer
37
Bailey Gregory
Director
15
Juvenescence Ltd
Director10% Owner
8
Ledger Steven A
OfficerDirector
5
Mintz Steven
Director
5

Showing 1-5 of 16

Page 1 of 4Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Agex Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#InsiderTradesWin rateAvgMedianBestWorst
1Moreadith Randall3194%+32.6%+37.1%+59.8%-25.0%
2Mintz Steven147%-20.6%-22.3%+2.6%-27.7%
3Bailey Gregory166%-19.6%-18.1%+2.9%-39.4%

All filings

95 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue